KHV-29454-51026
4 vaccinations
2 coded responses
51 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 193 / PA
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 1 — Moderna
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-17
- 2021-03-24
-
2021-03-31
Dose 2 — Moderna
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
-
2021-05-12
Survey response — day 42, dose 2MedDRA: Lymphadenopathy, Tonsillar hypertrophy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Swollen lymph nodes and tonsilsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-12
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-02
- 2021-09-29
-
2021-11-01
Dose 3 — Moderna
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-11-03
- 2021-11-04
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-12-01
- 2021-12-06
- 2021-12-13
- 2022-01-31
- 2022-04-15
- 2022-05-02
-
2022-10-04
Dose 4 — ModernaCo-administered: Flu
-
2022-10-05
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-10-06
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-07
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-11-08
- 2022-11-15
-
2023-01-03
Survey response — 3 months, dose 4MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Moderna | |
| 2 | 2021-03-31 | Moderna | |
| 3 | 2021-11-01 | Moderna | No |
| 4 | 2022-10-04 | Moderna | Flu |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 8 — day 42, dose 2
Symptoms: Swollen lymph nodes and tonsils
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Tonsillar hypertrophy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release